Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations

被引:8
|
作者
Hart, Nicolas H. [1 ,2 ,3 ,4 ,5 ]
Nekhlyudov, Larissa [6 ]
Smith, Thomas J. [7 ,8 ]
Yee, Jasmine [9 ]
Fitch, Margaret I. [10 ]
Crawford, Gregory B. [11 ,12 ]
Koczwara, Bogda [13 ,14 ]
Ashbury, Fredrick D. [15 ,16 ,17 ]
Lustberg, Maryam B. [18 ,19 ]
Mollica, Michelle [20 ]
Smith, Andrea L. [21 ,22 ]
Jefford, Michael [23 ,24 ]
Chino, Fumiko [25 ]
Zon, Robin [26 ,27 ]
Agar, Meera R. [28 ]
Chan, Raymond J. [2 ,4 ]
机构
[1] Univ Technol Sydney UTS, INSIGHT Res Inst, Fac Hlth, Human Performance Res Ctr, Sydney, NSW, Australia
[2] Flinders Univ S Australia, Caring Futures Inst, Coll Nursing & Hlth Sci, Adelaide, SA, Australia
[3] Edith Cowan Univ, Sch Med & Hlth Sci, Exercise Med Res Inst, Perth, WA, Australia
[4] Queensland Univ Technol QUT, Fac Hlth, Sch Nursing, Canc & Palliat Care Outcomes Ctr, Brisbane, Qld, Australia
[5] Univ Notre Dame Australia, Inst Hlth Res, Perth, WA, Australia
[6] Harvard Med Sch, Brigham & Womens Hosp, Internal Med, Boston, MA USA
[7] Johns Hopkins Med Inst, Div Gen Internal Med, Baltimore, MD USA
[8] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[9] Univ Sydney, Fac Med & Hlth, Ctr Med Psychol & Evidence Based Decis Making, Sydney, NSW, Australia
[10] Univ Toronto, Fac Nursing, Sch Grad Studies, Toronto, ON, Canada
[11] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia
[12] Northern Adelaide Local Hlth Network, Adelaide, SA, Australia
[13] Flinders Univ S Australia, Flinders Hlth & Med Res Inst, Coll Med & Publ Hlth, Adelaide, SA, Australia
[14] Flinders Med Ctr, Flinders Canc & Innovat Ctr, Adelaide, SA, Australia
[15] VieCure, Clin & Sci Div, Greenwood Village, CO USA
[16] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[17] Ohio State Univ, Coll Med, Internal Med Med Oncol, Columbus, OH USA
[18] Yale Univ, Sch Med, Dept Med, New Haven, CT USA
[19] Yale Canc Ctr, Med Oncol Div, New Haven, CT USA
[20] NCI, Off Canc Survivorship, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[21] Daffodil Ctr, Sydney, NSW, Australia
[22] Univ Sydney, Sydney, NSW, Australia
[23] Australian Canc Survivorship Ctr, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[24] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[25] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[26] Michiana Hematol Oncol, Mishawaka, IN USA
[27] Cincinnati Canc Advisors, Cincinnati, OH USA
[28] Univ Technol Sydney UTS, Fac Hlth, IMPACCT Res Ctr, Sydney, NSW, Australia
关键词
Survivorship; Supportive Care; Elements of Care; Cancer Survivors; Caregivers; SHARED DECISION-MAKING; AMERICAN SOCIETY; BREAST-CANCER; PALLIATIVE CARE; PROSTATE-CANCER; ADULT SURVIVORS; FAMILY-MEMBERS; MANAGEMENT; COMMUNICATION; STATEMENT;
D O I
10.1007/s00520-024-08465-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared to those with early-stage disease or those nearing the end-of-life. These MASCC-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer.Methods An expert panel comprising MASCC and ASCO members was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting: (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process.Results A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including 8 people with lived experience) across 33 countries (33% were low-to-middle resource countries) participated in the Delphi study and achieved >= 94.8% agreement for seven standards (1. Person-Centred Care; 2. Coordinated and Integrated Care; 3. Evidence-Based and Comprehensive Care; 4. Evaluated and Communicated Care; 5. Accessible and Equitable Care; 6. Sustainable and Resourced Care; 7. Research and Data-Driven Care) and >= 84.2% agreement across 45 practice recommendations.Conclusion Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards will support optimization of health outcomes and care experiences by providing guidance to stakeholders in cancer care (healthcare professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers. Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts.
引用
收藏
页数:15
相关论文
共 44 条
  • [31] Providing general practice needs-based care for carers of people with advanced cancer: a randomised controlled trial
    Mitchell, Geoffrey K.
    Girgis, Afaf
    Jiwa, Moyez
    Sibbritt, David
    Burridge, Letitia H.
    Senior, Hugh E.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2013, 63 (615): : E683 - E690
  • [32] Clinical practice guideline:: 2003 Update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)
    Conroy, T
    Gory-Delabaere, G
    Adenis, A
    Bosquet, L
    Bouché, O
    Louvet, C
    Mitry, E
    Bécouarn, Y
    Bosset, JF
    Ducreux, M
    Etienne, PL
    Merrouche, Y
    Monges, G
    Rougier, P
    BULLETIN DU CANCER, 2004, 91 (10) : 759 - 768
  • [33] CANCER FERTILITY PRESERVATION MADE EASY! ACHIEVING OPTIMAL PATIENT CARE AND AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) STANDARDS.
    Grabowski, Maria
    Clayton, Stephanie
    Spitzer, Deborah
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E147 - E148
  • [34] Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update
    Ramakrishna, Naren
    Temin, Sarah
    Chandarlapaty, Sarat
    Crews, Jennie R.
    Davidson, Nancy E.
    Esteva, Francisco J.
    Giordano, Sharon H.
    Kirshner, Jeffrey J.
    Krop, Ian E.
    Levinson, Jennifer
    Modi, Shanu
    Patt, Debra A.
    Perlmutter, Jane
    Winer, Eric P.
    Lin, Nancy U.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (27) : 2804 - +
  • [35] Response to Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23
    Katherine Clark
    David C. Currow
    Supportive Care in Cancer, 2020, 28 : 2041 - 2042
  • [36] Response to Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23
    Clark, Katherine
    Currow, David C.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (05) : 2041 - 2042
  • [37] Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update Summary
    Ramakrishna, Naren
    Temin, Sarah
    Lin, Nancy U.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (08) : 505 - +
  • [38] Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
    Masaya Hattori
    Naoko Honma
    Shigenori Nagai
    Kazutaka Narui
    Tomoko Shigechi
    Yukinori Ozaki
    Masayuki Yoshida
    Takashi Sakatani
    Eiichi Sasaki
    Yuko Tanabe
    Junji Tsurutani
    Toshimi Takano
    Shigehira Saji
    Shinobu Masuda
    Rie Horii
    Hitoshi Tsuda
    Rin Yamaguchi
    Tatsuya Toyama
    Chikako Yamauchi
    Masakazu Toi
    Yutaka Yamamoto
    Breast Cancer, 2024, 31 : 335 - 339
  • [39] Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
    Hattori, Masaya
    Honma, Naoko
    Nagai, Shigenori
    Narui, Kazutaka
    Shigechi, Tomoko
    Ozaki, Yukinori
    Yoshida, Masayuki
    Sakatani, Takashi
    Sasaki, Eiichi
    Tanabe, Yuko
    Tsurutani, Junji
    Takano, Toshimi
    Saji, Shigehira
    Masuda, Shinobu
    Horii, Rie
    Tsuda, Hitoshi
    Yamaguchi, Rin
    Toyama, Tatsuya
    Yamauchi, Chikako
    Toi, Masakazu
    Yamamoto, Yutaka
    BREAST CANCER, 2024, 31 (03) : 335 - 339
  • [40] Concordance to National Comprehensive Cancer Network (NCCN) clinical practice guideline (GL) drug therapy recommendations for metastatic breast cancer: An analysis from the commercial managed care claims database PharMetrics (PM)
    Lepisto, E. M.
    Tangirala, K.
    Vandergrift, J. L.
    McClure, J. S.
    McNally, D. L.
    Mullins, C. D.
    Seal, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)